07 June 2022
: Case report
Thrombotic Microangiopathy Secondary to Systemic Sclerosis with Severe Complement Activation Not Responsive to Eculizumab: A Case Report
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction
Masahiko Nakamura1ABCDEF*, Tomohiro Abe
DOI: 10.12659/AJCR.936116
Am J Case Rep 2022; 23:e936116